According to county data, only around 7% of residents have received COVID-19 boosters this season, and 22% have gotten flu ...
The preventive effects of nirsevimab against respiratory syncytial virus infection persisted for up to 12 months after ...
A pooled multicountry analysis shows that immunisation with nirsevimab effectively reduced RSV-related hospitalisation in ...
A winter virus that can mimic the symptoms of a common cold is causing concern as it can be particularly serious for some ...
A virus that can easily spread across the winter period can show a variety of symptoms similar to the common cold; however, ...
VBY329 is designed for the prevention of Respiratory Syncytial Virus (RSV) infections in newborns, infants, and children, and results from ...
A virus that can easily spread across the winter period can show a variety of symptoms similar to the common cold; however, ...
Heading into the holidays, Maryland is seeing low levels of flu, COVID and RSV. Doctors said it's important to get your ...
The CDC tracks what is happening nationally and says RSV in many southern and southeastern states is starting to increase, ...
Sanofi and AstraZeneca's Beyfortus (Nirsevimab) is now approved by the National Pharmaceutical Regulatory Agency (NPRA) and is available for the prevention of respiratory syncytial virus (RSV) lower ...
Parents in Malaysia now have access to Beyfortus (nirsevimab), a newly approved preventive treatment designed to protect ...
Veterans aged 60 years and older who received a single dose of the respiratory syncytial virus (RSV) prefusion F3 (RSVPreF3) or RSV prefusion F (RSVpreF) vaccine remained protecte ...